Acceder Registro /

Manuel Muro Amador

Buscador

Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos MJ, Galian JA, Botella C, Moya-Quiles R, Muro-Perez M, Minguela A, Llorente S, Muro M. MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. Biomedicines. 2024 Jan 5;12(1):116. doi: 10.3390/biomedicines12010116. PubMed PMID: 38255221.
AÑO: 2024; IF: 4.7
Collados-Ros A, Muro M, Legaz I. Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review. Biomedicines. 2024 Jan 17;12(1):208. doi: 10.3390/biomedicines12010208. PubMed PMID: 38255313.
AÑO: 2024; IF: 4.7
Legaz I, Navarro-Noguera E, Collados-Ros A, Bolarin JM, Muro M. Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis. Biomedicines. 2024 Feb 1;12(2):336. doi: 10.3390/biomedicines12020336. PubMed PMID: 38397937; PubMed Central PMCID: PMC10887413.
AÑO: 2024; IF: 4.7
Legaz I, Muro M. Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes. Int J Mol Sci. 2023 Apr 24;24(9):7743. doi: 10.3390/ijms24097743. PubMed PMID: 37175450; PubMed Central PMCID: PMC10178591.
AÑO: 2023; IF: 5.6
Legaz I, Morales R, Bolarin JM, Collados-Ros A, Pons JA, Muro M. Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles? Biomedicines. 2023 Aug 28;11(9):2405. doi: 10.3390/biomedicines11092405. PubMed PMID: 37760846; PubMed Central PMCID: PMC10525207.
AÑO: 2023; IF: 4.7

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R